Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stock Charts To Watch: ENDP, INMD, NIO, NNVC, NVAX, UBER

Published 01/22/2020, 12:19 AM
Updated 07/09/2023, 06:31 AM

1. Endo International (ENDP)

Endo International (NASDAQ:ENDP) popped 34 cents, or 5.63%, to 6.38, on Tuesday, after reaching a high of 6.54, on 11 million shares traded. At the top of the channel, the lateral resistance goes back to April-May. If it does extend, the target is 7 1/2, and beyond that, look for 8-8 1/4.

2. InMode Ltd. (INMD)

InMode (NASDAQ:INMD) jumped 1.94, or 4.3%, to 46.99, after running up to 47.31, on 1.4 million shares on Tuesday. It continues to move out of the falling wedge, and after backing off four days ago, it ran up to the highest closing since Dec 5, about six weeks ago. I think it’s headed to 55, and then 62.

3. NIO (NIO)

Nio (NYSE:NIO) has been running beautifully. First of all, it had a long downtrend, then a breakaway explosive move, pulled back to the channel on low volume, and now it’s been up for nine straight day. On Tuesday, it gained another 50 cents, or 11%, and after running up to an 8-month high of 5.29, it pulled back and closed up 5.17, on 180.4 million shares. It’s at resistance and may pull back, but if it pushes up through resistance, targets are 6 1/2 and 8 1/4 going forward.

4. NanoViricides (NNVC)

NanoViricides (NYSE:NNVC), a vaccine drug, exploded 5.14, or 153%, to 8.50, on 4.4 million shares, and was up another 75 cents, or 8.83%, in after-hours. After reaching a high of 13.45 earlier in the day, it stabilized, not only at the end of the day, but in after-hours as well. My thinking is that if the trendline holds, it could very well go wave five to the upside. If it tests the 13.50 range, it’s off to the races.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

5. Novavax, Inc. (NVAX)

Novavax (NASDAQ:NVAX) on drug news, formed a breakaway gap on monster volume of 64 million shares, running up 4.08, or 71%, to 9.82, not far off the session high at 9.99. It looks to me like it might have more to go. I’m looking for a test of 13 in the next couple days.

6. Uber (UBER)

Uber Technologies (NYSE:UBER) looks like it broke out on Tuesday. After snapping back and doing a Fibonacci retracement, it ran up 2.47, or 7%, ran up to 37.80, before pulling back and closing up 37.60, on 47 million shares, and was up an additional 37 cents in after-hours. It was a big day for this stock. It looks to me like it has some resistance in here, and if it should extend, I will be looking at something around 40 as the next target.

Stocks on the long side

Avaya Holdings Corp. (AVYA), Beyond Meat, Inc. (NASDAQ:BYND), Endo International plc (ENDP), FuelCell Energy, Inc. (FCEL), InMode Ltd. (INMD), Inseego Corp. (INSG), Repro Med Systems, Inc. (KRMD), Maxar Technologies Inc. (MAXR), Mallinckrodt (NYSE:MNK) Public Limited Company (MNK), MagnaChip Semiconductor Corporation (MX), NIO Inc. (NIO), Neoleukin Therapeutics, Inc. (NLTX), NanoViricides, Inc. (NNVC), Novavax, Inc. (NVAX), ObsEva SA (OBSV), Oncolytics Biotech Inc. (ONCY), Predictive Technology Group, Inc. (PRED), RadNet, Inc. (RDNT), Soliton, Inc. (SOLY), Virgin Galactic Holdings, Inc. (SPCE), Tesla, Inc. (NASDAQ:TSLA), Uber Technologies, Inc. (NYSE:UBER), and Wrap Technologies, Inc. (WRTC).

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.